Certified by Founder Lodge
Hemab Therapeutics
Denmark - Copenhagen, Capital Region
START UP
1 Disclosed Funding Rounds $135,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhag
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 22 ,2023 | Series B | $135,000,000 |
Access Industries
The Invus Group
Novo Holdings
RA Capital Management, L.P.
Avoro Capital Advisors
Rock Springs Capital
Maj Invest
HealthCap
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)